by Milan Mračno, Member of the Board of Directors and Chief Financial Officer, PRO.MED.CS Praha a.s.
PRO.MED.CS Praha is predominantly an export business, with nearly three-quarters of its total production currently exported. Foreign sales are typically conducted in USD, EUR and more recently RUB; similarly, many of our suppliers invoice us in USD or EUR. We aim to make our payments in the currencies of our international receivables, i.e., reduce the need for foreign currency conversion which has an impact on exchange rate risk as well as cost.
PRO.MEDS.CS trades in many demanding markets and CSOB has always proved a reliable and knowledgeable partner.
We export into a number of markets in Eastern Europe and Central Asia where the payment terms are 180 days or more, which creates working capital challenges for PRO.MED.CS. We fund this period between delivery and payment through an overdraft facility which is expensive. On one hand, the company has high credit balances on RUB accounts; on the other hand, a permitted EUR overdraft is used.
Ever since our incorporation, we have had a relationship with ˜CSOB. Initially, we worked with the bank for payments, both domestic and international, but the relationship has subsequently expanded to investment financing and leasing. PRO.MED.CS trades in many demanding markets, e.g., Kazakhstan, Uzbekistan, Belarus etc. and ˜CSOB has always proved a reliable and knowledgeable partner. However, our company has a number of banking partners, so we contacted each of them, including ˜CSOB, to request a proposal for the best solution to include operation financing in relation to higher RUB balances and protection from adverse exchange rate developments.
Sign up for free to read the full articleRegister Login with LinkedIn
Already have an account?Login
Download our Free Treasury App for mobile and tablet to read articles – no log in required.Download Version Download Version